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MaBACKGROUND Diagnosis, treatment, and outcomes of acute aortic dissection (AAS) are changing.
OBJECTIVES This study examined 17-year trends in the presentation, diagnosis, and hospital outcomes of AAD from
the International Registry of Acute Aortic Dissection (IRAD).
METHODS Data from 4,428 patients enrolled at 28 IRAD centers between December 26, 1995, and February 6, 2013, were
analyzed.Patientsweredividedaccording toenrollmentdate into6equalgroupsandbyAADtype:A (n¼ 2,952)orB (n¼ 1,476).
RESULTS There was no change in the presenting complaints of severe or worst-ever pain for type A and type B AAD
(93% and 94%, respectively), nor in the incidence of chest pain (83% and 71%, respectively). Use of computed to-
mography (CT) for diagnosis of type A increased from 46% to 73% (p < 0.001). Surgical management for type A
increased from 79% to 90% (p < 0.001). Endovascular management of type B increased from 7% to 31% (p < 0.001).
Type A in-hospital mortality decreased signiﬁcantly (31% to 22%; p < 0.001), as surgical mortality (25% to 18%;
p ¼ 0.003). There was no signiﬁcant trend in in-hospital mortality in type B (from 12% to 14%).
CONCLUSIONS Presenting symptoms and physical ﬁndings of AAD have not changed signiﬁcantly. Use of chest CT
increased for type A. More patients in both groups were managed with interventional procedures: surgery in type A
and endovascular therapy in type B. A signiﬁcant decrease in overall in-hospital mortality was seen for type A but not for
type B. (J Am Coll Cardiol 2015;66:350–8) © 2015 by the American College of Cardiology Foundation.M uch has been written about the challengesof diagnosing and treating acute aorticdissection (AAD) and the lethal conse-
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AB BR E V I A T I O N S
AND ACRONYM S
AAD = acute aortic dissection
CT = computed tomography
MR = magnetic resonance
TEE = transesophageal
echocardiography
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351have increased the public’s awareness of what re-
mains a very dangerous and unpredictable condition
(3,4). Over the past 2 decades, the exciting discovery
of genetic mechanisms underlying thoracic aortic dis-
ease has begun to affect medical treatment (5,6).
Greater availability and increased use of advanced im-
aging modalities, particularly computed tomography
(CT), have the potential to improve the diagnosis of
AAD (7,8). Improvement in surgical and anesthetic
techniques have led to improved survival of patients
with type A dissection, whereas the expanded use of
endovascular interventions is having a growing effect
on management of type B dissection (9,10).SEE PAGE 359AAD usually results from a tear in the aortic intima,
which allows a pressurized hematoma to form within
the media between the inner two-thirds and outer
one-third of the aorta. The blood typically propagates
rapidly along the length of the aorta and often com-
promises branch vessels along its path and/or dis-
rupts aortic valve function, which causes aortic
insufﬁciency. Because the blood in the false lumen is
contained by only the thin outer third of the media
and the loose adventitial connective tissue, rupture
into the pericardial space, pleural space, or medias-
tinum is common. Thus, AAD represents a medical
and/or surgical emergency.
Although severe, abrupt onset, chest or back pain
is widely known as the classic presentation of AAD, a
signiﬁcant minority of AADs are not diagnosed in life
(11–14). Because autopsies are infrequently performed
in the current era, the frequency of missed diagnoses
of AAD is unknown (14). Many patients with AAD are
diagnosed and treated as having acute coronary syn-
drome, which is a much more frequent condition than
AAD. Patients who present without pain present a
diagnostic challenge and are more likely to have a
missed or delayed diagnosis (13–16). Advanced imag-
ing, especially CT, has been employed with increasing
frequency in emergency departments for the “triple
rule out,” but whether this practice has improved the
diagnosis of AAD is unknown (17). Surgical treatment
is indicated for all type A AADs, and medical man-
agement is used for uncomplicated type B AAD;
however, long-term outcomes indicate signiﬁcant
late mortality from late complications in both groups
(18). These complications, especially those that
involve the descending thoracic aorta of type B AAD
or operated type A patients with persistent false lu-
mens, are increasingly being managed by endovas-
cular techniques (19–21).
The International Registry of Acute Aortic Dissec-
tion (IRAD) was established in 1996 for the purpose ofenrolling patients at major aortic centers to
assess the presentation, management, and
outcomes of AAD (22). IRAD, which includes
28 international referral centers, is a unique
registry that currently allows examination
of trends in patient presentation, use of
advanced imaging (CT, transesophageal
echocardiography [TEE], and magnetic reso-
nance [MR]), management, and hospital outcomes
over 17 years of prospective data collection.
METHODS
PATIENT SELECTION. Twenty-eight referral centers
throughout North America, Europe, and Asia partici-
pated in this study. Data were collected on an unse-
lected population of all 4,428 IRAD patients who
presented with AAD from January 1996 through
February 2013. Patients included in the study were
identiﬁed at hospital presentation, on the basis of
hospital imaging or surgical databases and/or by
searching hospital diagnosis records. The diagnosis
of AAD was based on patient history, diagnostic
testing (including imaging results), operative ﬁnd-
ings, and/or autopsy results. Institutional Review
Board approval for this study was obtained at each
participating institution.
Data on patient demographic characteristics,
presenting history, physical examination, imaging
studies, management, and hospital outcomes were
collected by each of the 28 IRAD referral centers and
entered into case report forms developed by IRAD
investigators; these forms include 290 variables.
Case report forms were collected and reviewed by
the IRAD Coordinating Center at the University of
Michigan.
Patients identiﬁed as having either type A
(n ¼ 2,952) or type B AAD (n ¼ 1,476) were divided
into 6 equal groups based on 6 roughly equal time
spans in chronological order over the 17-year period.
Group data were analyzed for historical trends
in demographic characteristics, presentation, evalu-
ation, management, and hospital outcomes.
STATISTICAL ANALYSIS. Categorical variables were
compared using 2-sided chi-square analysis or Fisher’s
exact test where appropriate. Linear-by-linear associ-
ation was used to evaluate linear trends across time
groups. Differences among patient groups stratiﬁed
by time periods for continuous variables were deter-
mined utilizing 1-way analysis of variance. A p value
of #0.05 was considered statistically signiﬁcant.
SPSS (version 20.0, IBM Corp., Armonk, New York)
was used for all analyses.
TABLE 1 Demograph
Category
Demographics
Age, yrs
Male
Referred from prima
site to IRAD cent
Ethnicity
White
Asian
Black
Hispanic
Other
Patient history
Marfan syndrome
Hypertension
Atherosclerosis
Known aortic aneury
Previous AAD
Diabetes mellitus
Previous cardiac surg
Aortic valve replacem
Aortic aneurysm and
Coronary artery bypa
graft surgery
Mitral valve replacem
Iatrogenic
Values are mean  SD or n
AAD ¼ acute aortic disse
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352RESULTS
DEMOGRAPHICS CHARACTERISTICS. Across the 17-year
period, a total of 67% (n ¼ 2,952) of all patients
enrolled in IRAD presented with type A AAD, whereas
the remaining 33% (n ¼ 1,476) presented with type B
AAD (Table 1). The mean age of patients with type A
AAD was 62  14.6 years. The mean age of those with
type B AAD was older, at 64  14.1 years. Two-thirds
of patients were men, a proportion that did not
change over time. The majority of patients enrolled in
the overall study were identiﬁed as white (87%).
Almost 70% of all patients were referred from a pri-
mary site to an IRAD center. An increase was seen in
the proportion of patients referred from a primary site
to an IRAD center for type A patients over the 17-year
period (from 62% to 71%) but there was no signiﬁcant
trend for type B patients (from 62% to 68%).
Slightly>4%of all patients enrolled in the study had
Marfan syndrome (5% and 4% of type A and type B
AAD, respectively). Over time, fewer patients pre-
senting with type A AAD also had Marfan syndrome,
whereas the proportion of those presentingwith type B
AAD who had Marfan syndrome did not change
signiﬁcantly. A majority of patients had a history ofics and History of Patients With Acute Aortic Dissection
Total
(N ¼ 4,428)
Type A
(n ¼ 2,952)
Type B
(n ¼ 1,476)
p Value
Type A vs. Type B
61.5  14.6 63.6  14.1 <0.001
2,964 (66.9) 1,992 (67.5) 972 (65.8) 0.272
ry
er
3,089 (69.7) 2,022 (68.5) 1,067 (72.2) 0.010
3,609 (86.4) 2,455 (88.6) 1,154 (82.1) <0.001
184 (4.4) 101 (3.6) 83 (5.9)
295 (7.1) 164 (5.9) 131 (9.3)
57 (1.4) 29 (1.0) 28 (2.0)
31 (0.7) 22 (0.8) 9 (0.6)
178 (4.4) 122 (4.5) 56 (4.0) 0.404
3,247 (76.6) 2,089 (74.4) 1,158 (80.9) <0.001
1,079 (26.5) 636 (23.8) 443 (31.7) <0.001
sm 628 (15.5) 337 (12.7) 291 (20.7) <0.001
232 (5.7) 107 (4.0) 125 (8.9) <0.001
316 (7.8) 204 (7.7) 112 (8.0) 0.673
ery 643 (16.1) 374 (14.2) 269 (19.6) <0.001
ent 203 (5.1) 118 (4.5) 85 (6.2) 0.022
/or AAD 368 (9.2) 168 (6.4) 200 (14.5) <0.001
ss 196 (4.9) 130 (5.0) 66 (4.8) 0.851
ent 35 (0.9) 24 (0.9) 11 (0.8) 0.726
118 (2.8) 85 (3.0) 33 (2.3) 0.212
(%).
ction; IRAD ¼ International Registry of Acute Aortic Dissection.hypertension (77% overall), which was more preva-
lent in those with type B AAD than in those with type A
AAD (81% vs. 74%). This prevalence did not change.
PRESENTING SYMPTOMS AND PHYSICAL EXAMINATION.
Most patients presented with severe pain of abrupt
onset, regardless of AAD type. Overall, over time, there
was no change in the presenting complaint of severe or
worst-ever pain (93% in type A, 94% in type B) or in the
incidence of chest pain (83% in type A, 71% in type B).
Overall, a higher proportion of patients with type A
complained of chest pain (85% in type A vs. 67% in
type B), and more patients with type B reported back
pain (70%) compared with those with type A AAD
(43%). Far more patients with type A presented with
syncope than those with type B, with no change over
time (19% and 3%, respectively). More patients with
type B presented with hypertension than patients with
type A (66% and 28%, respectively), with no difference
seen over time. There was no change in the prevalence
of pulse deﬁcits on presentation for type A or for type B
(type A: 31% and type B: 19%).
DIAGNOSTIC TESTING. In the later years of data
collection, fewer abnormal chest x-rays were reported
for both type A and type B AAD patients. Reports of
a widened mediastinum on chest x-ray decreased
among those with type A (from 61% to 52%) and
among those with type B (from 56% to 39%).
Furthermore, reports of a normal chest x-ray on pre-
sentation increased signiﬁcantly in type A (from 13%
to 29%) and in type B (from 19% to 36%).
A normal electrocardiogram was noted in 36% of
type A patients and 38% of type B patients and
increased slightly over time in both type A and type B
patients.
The frequency of the use of chest CT as the initial
diagnostic imaging modality increased over time in
type A patients, from 46% to 73%, over the 17-year
period. However, the frequency in type B patients
did not change. Conversely, the use of TEE as the ﬁrst
diagnostic imaging study decreased from 50% to 23%
in type A patients. TEE was used less often (12%) to
initially evaluate those with type B, with no change
over time. Invasive aortography and MR imaging
were rarely used as initial diagnostic imaging mo-
dalities, and the frequency of their use did not change
over time for either dissection type.
MANAGEMENT AND OUTCOMES. Discharge medica-
tions changed signiﬁcantly over time. In type A
AAD, patients were more frequently discharged on
beta-blockers, diuretics, and statins in the later time
periods. Fewer vasodilators were prescribed in this
group. Compared with earlier time periods, more
recent type B patients were more commonly given
TABLE 2 Management and Outcomes of Acute Aortic Dissection
Category
Type A (n ¼ 2,952)
Management
Type B (n ¼ 1,476)
Management
Surgical Medical Endo Hybrid Surgical Medical Endo Hybrid
n 2,552 (86.4) 329 (11.1) 34 (1.2) 36 (1.2) 192 (13.0) 923 (62.5) 341 (23.1) 21 (1.4)
In-hospital mortality* 502 (19.7) 188 (57.1) 24 (70.6) 5 (13.9) 33 (17.2) 80 (8.7) 42 (12.3) 3 (14.3)
Total mortality (p < 0.001) 721 (24.4) 158 (10.7)
Values are n (%). *p < 0.001 for Type A mortality between management types; p ¼ 0.003 for Type B mortality between management types.
Endo ¼ endovascular.
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353angiotensin receptor blockers, beta-blockers, and
statins and also showed a decrease in the prescription
of other vasodilators.
Themajority of patients presenting with type A AAD
were managed surgically (86% overall) (Table 2), withTABLE 3 Trends in Type A Dissection
Category Group 1 Group 2 Grou
History and demographics
Age, yrs 61.3  14.8 60.7  15.1 61.3 
Male 314 (64.1) 316 (67.2) 350 (
White 377 (88.5) 401 (91.8) 461 (
Referred from primary center 304 (62.0) 312 (66.4) 344 (
Marfan syndrome 26 (5.7) 26 (6.2) 17 (
Hypertension 331 (70.9) 330 (73.0) 371 (
Atherosclerosis 124 (27.0) 121 (28.3) 109 (
Previous cardiac surgery 69 (16.4) 82 (21.0) 67 (
Presenting symptoms and signs
Severe or worst-ever pain 362 (91.6) 309 (92.5) 367 (
Chest pain: anterior 313 (78.3) 293 (75.9) 333 (
Tearing or ripping pain 112 (64.4) 88 (80.0) 75 (
Syncope 67 (16.1) 82 (20.8) 94 (
Presenting hypertension 134 (28.8) 114 (25.9) 105 (
Pulse deﬁcits on presentation 112 (29.6) 90 (28.8) 105 (
Normal chest x-ray 49 (12.7) 49 (14.6) 74 (
Widened mediastinum on chest x-ray 233 (60.8) 195 (59.3) 158 (
Normal ECG 152 (33.5) 135 (31.3) 153 (
Use of CT as initial imaging modality 214 (45.8) 232 (54.5) 299 (
Use of TEE as initial imaging modality 233 (49.9) 178 (41.8) 176 (
Discharge medications
ACE inhibitors 124 (39.2) 118 (38.4) 115 (
Angiotensin II receptor blockers 1 (33.3) 3 (14.3) 6 (
Beta-blockers 248 (76.3) 263 (84.6) 253 (
Calcium-channel blockers 104 (34.2) 110 (37.5) 105 (
Diuretics 13 (86.7) 10 (43.5) 16 (
Statins 0 (0.0) 2 (11.1) 7 (
Vasodilators 57 (19.1) 56 (19.4) 37 (
In-hospital management and outcomes
Surgical management 384 (78.7) 409 (87.0) 439 (
Medical management 99 (20.3) 57 (12.1) 53 (
Overall mortality 154 (31.4) 119 (25.3) 140 (
Surgical mortality 96 (25.0) 80 (19.6) 97 (
Medical mortality 54 (54.5) 37 (64.9) 34 (
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; CT ¼ computerized tomography; ECG ¼ electsigniﬁcantlymore operative procedures undertaken in
the later time periods (79% to 90%) (Table 3). Over
time, the in-hospital mortality rate of patients pre-
senting with type A decreased signiﬁcantly from
31% to 22% (Figure 1), primarily due to a decline in thep 3 Group 4 Group 5 Group 6 p Value Trend p Value
14.5 61.4  14.7 61.9  14.0 62.5  14.4 0.540 —
68.9) 339 (71.1) 345 (66.5) 328 (67.1) 0.294 0.413
94.7) 394 (86.2) 420 (85.5) 402 (85.0) <0.001 0.009
67.7) 351 (73.6) 365 (70.3) 346 (70.8) 0.003 <0.001
4.0) 23 (5.1) 10 (2.1) 20 (4.5) 0.041 0.033
79.3) 327 (70.8) 382 (76.7) 348 (75.5) 0.014 0.125
25.6) 91 (20.4) 107 (22.2) 84 (19.4) 0.006 <0.001
15.2) 60 (13.4) 49 (10.1) 47 (10.6) <0.001 <0.001
94.1) 353 (92.4) 398 (92.6) 365 (93.1) 0.854 0.604
83.7) 307 (85.5) 323 (93.4) 328 (93.4) <0.001 <0.001
49.7) 75 (27.3) 58 (16.7) 72 (23.8) <0.001 <0.001
22.9) 60 (13.6) 84 (17.2) 93 (21.6) 0.003 0.648
23.5) 135 (32.0) 138 (28.6) 121 (27.0) 0.108 0.674
32.5) 99 (29.6) 88 (31.5) 75 (31.9) 0.885 0.451
25.2) 92 (31.6) 99 (30.1) 72 (28.6) <0.001 <0.001
54.5) 118 (42.8) 130 (43.6) 108 (52.2) <0.001 <0.001
35.4) 143 (36.4) 178 (38.9) 166 (40.7) 0.050 0.002
61.1) 313 (70.5) 326 (68.2) 312 (72.9) <0.001 <0.001
36.0) 122 (27.5) 134 (28.0) 99 (23.1) <0.001 <0.001
43.7) 114 (41.8) 165 (47.1) 144 (43.2) 0.234 0.051
7.8) 9 (7.8) 64 (22.5) 35 (11.4) <0.001 0.555
86.9) 249 (86.2) 331 (85.8) 304 (87.6) 0.001 <0.001
40.5) 99 (36.4) 110 (31.9) 121 (36.1) 0.347 0.602
22.9) 41 (36.9) 104 (37.5) 166 (53.2) <0.001 0.016
10.6) 16 (20.8) 77 (30.9) 107 (38.8) <0.001 <0.001
14.7) 25 (11.3) 24 (9.4) 20 (7.2) <0.001 <0.001
86.4) 424 (88.9) 455 (87.7) 441 (90.2) <0.001 <0.001
10.4) 35 (7.3) 46 (8.9) 39 (8.0) <0.001 <0.001
27.6) 99 (20.8) 103 (19.8) 106 (21.7) <0.001 <0.001
22.1) 76 (17.9) 72 (15.8) 81 (18.4) 0.015 0.003
64.2) 17 (48.6) 24 (52.2) 22 (56.4) 0.512 0.626
rocardiography; TEE ¼ transesophageal echocardiogram.
FIGURE 1 Mortality Over Time by Dissection Type
50.0%
45.0%
40.0%
35.0%
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25.0%
20.0%
15.0%
10.0%
5.0%
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Group 1
12/26/95-
2/14/99
Group 2
2/16/99-
3/25/02
Group 3
3/25/02-
8/1/05
Group 4
8/7/05-
11/22/07
Group 5
11/22/07
2/24/10
Group 6
2/24/10-
2/6/13
Overall Mortality - Type A (p for trend <0.001)
Overall Mortality - Type B (p for trend 0.915)
Trends in mortality among patients with type A and type B acute aortic dissection over
17 years of International Registry of Acute Aortic Dissection data collection.
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354surgical mortality rate from 25% to 18% (Central
Illustration). The in-hospital mortality rate among
thosemanagedmedically remained high (57%) and did
not change. Endovascular repair alone was performed
to treat distal malperfusion in a very limited number of
Type A patients; these patients had a high mortality
rate (71% overall).
The majority of patients with type B AAD were
treated medically (63% of the entire cohort). This
percentage decreased (75% to 57%) as endovascular
management increased from 7% to 31% (Table 4).
Traditional surgical management of type B also
decreased (17% to 8%), although there was an in-
crease in hybrid procedures that used surgical
debranching techniques (left subclavian artery bypass
or transposition) to facilitate endovascular interven-
tion (0% to 5%). The overall in-hospital mortality rate
of patients presenting with type B did not change
signiﬁcantly (Figure 1). Although a decreasing number
of type B patients underwent surgical management,
the mortality for these few patients improved over
time, which possibly suggests an improved selection
of management strategy for those patients who
required further intervention.
DISCUSSION
Acute aortic dissection is a life-threatening condition
that remains challenging to diagnose and treat.Patients present as acutely ill with a variety of
symptoms and signs, many of which can mimic more
common conditions such as myocardial ischemia or
pulmonary embolism. Since their ﬁrst publication in
2000, IRAD investigators have reported a number of
clinical observations derived from the large registry
of patients with AAD, not only to raise awareness of
this challenging and often fatal condition but also to
provide insights to help guide diagnosis and treat-
ment (22,23). These reports have included snapshot
observations regarding presenting symptoms, phys-
ical ﬁndings, results of diagnostic imaging, manage-
ment, and hospital outcomes of patients with both
type A and type B AAD. In this analysis, we have
sought to evaluate the temporal changes in these
parameters over a 17-year time frame.
Notably, patients with type A dissection were
increasingly transferred from referral centers to IRAD
hospitals. Although IRAD could not discern the exact
reasons for this trend, it is possible that increased
attention to the need for emergent surgery in this pa-
tient population precipitated the rise in transfers. In
addition, the increased use of CT imaging over time in
typeA patients (but not type B)might have contributed
to earlier recognition of type A AAD. As reported by
IRAD and many earlier investigators, severe or worst-
ever chest pain continues to be the most common
presenting feature in both type A and type B AAD
(24,25). One dramatic change, however, has been the
decrease in the reporting of “ripping or tearing” pain
among patients with AAD. This is in contrast to earlier
studies that highlighted the characteristics of ripping
and tearing, along with “migratory,” as common terms
used by patients to describe the quality of their pre-
senting pain and as a way of differentiating pain that
suggested AAD from that indicating other clinical
conditions (25). We believe this difference in qualita-
tive pain description is likely related to a change in
emphasis on history taking and/or data collection,
rather than an actual change in presenting symptoms.
In addition, retrospective data collection from hospital
records for the majority of the registry patients might
also not have captured this information accurately.
Patients with type B AAD remain more likely to
presentwith hypertension than thosewith type AAAD.
As expected, patients with type A are more likely to
present with pulse deﬁcits, an observation that has not
changed over time. However, pulse deﬁcits are iden-
tiﬁed in only a minority of patients with dissection,
and thus have little negative predictive value.
With regard to diagnostic testing, chest x-rays
historically have been said to “almost always reveal
an abnormal aortic contour” (25,26). For example,
in 1 study that antedated the use of modern
CENTRAL ILLUSTRATION Trends in Acute Aortic Dissection Over 17 Years
Pape, L.A. et al. J Am Coll Cardiol. 2015; 66(4):350–8.
Type A (n ¼ 2,952) and type B (n ¼ 1,476) acute aortic dissection patients divided into equal-sized groups based on time of enrollment, 1996 to 2013.
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TABLE 4 Trends in Type B Dissection
Category Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 p Value Trend p Value
History and demographics
Age, yrs 66.7  12.7 61.8  13.9 63.9  14.0 61.7  14.5 63.1  15.0 64.7  14.2 <0.001 —
Male 173 (69.8) 180 (67.2) 146 (63.2) 178 (68.2) 137 (62.3) 158 (63.5) 0.400 0.108
White 191 (82.3) 207 (80.9) 195 (87.1) 190 (78.8) 162 (77.5) 209 (86.0) <0.001 0.617
Referred from primary center 153 (61.7) 205 (76.5) 175 (75.8) 204 (78.2) 160 (72.7) 170 (68.3) <0.001 0.327
Marfan syndrome 5 (2.1) 15 (5.7) 7 (3.1) 7 (2.9) 13 (6.2) 9 (4.0) 0.140 0.363
Hypertension 193 (79.1) 203 (76.9) 191 (83.8) 204 (83.6) 172 (80.4) 195 (82.3) 0.310 0.190
Atherosclerosis 98 (41.4) 85 (32.2) 81 (36.2) 50 (21.1) 57 (27.1) 72 (32.0) <0.001 0.003
Known aortic aneurysm 48 (19.9) 52 (19.9) 49 (21.9) 52 (21.4) 44 (21.1) 46 (20.4) 0.993 0.803
Presenting symptoms and signs
Severe or worst-ever pain 200 (93.0) 198 (95.2) 175 (94.1) 203 (91.9) 186 (94.4) 201 (93.3) 0.781 0.995
Chest pain: anterior 109 (54.0) 143 (64.7) 99 (58.9) 116 (70.7) 109 (80.1) 129 (78.2) <0.001 <0.001
Tearing or ripping pain 74 (67.3) 71 (79.8) 52 (56.5) 46 (28.4) 51 (29.1) 51 (29.7) <0.001 <0.001
Syncope 6 (2.5) 11 (4.2) 4 (1.9) 6 (2.5) 5 (2.5) 13 (6.0) 0.129 0.223
Presenting hypertension 169 (69.0) 164 (63.1) 151 (70.6) 137 (60.4) 139 (68.8) 141 (63.5) 0.134 0.432
Pulse deﬁcits on presentation 31 (14.9) 48 (20.9) 30 (15.9) 36 (17.8) 30 (21.0) 33 (24.3) 0.220 0.075
Normal chest x-ray 46 (19.4) 36 (15.7) 55 (28.8) 74 (36.8) 62 (35.2) 62 (36.3) <0.001 <0.001
Widened mediastinum 132 (56.4) 117 (52.5) 63 (34.2) 57 (30.8) 51 (32.5) 50 (39.1) <0.001 <0.001
Normal ECG 74 (31.1) 67 (26.7) 81 (38.9) 91 (42.1) 93 (47.7) 100 (47.4) <0.001 <0.001
Use of CT as initial imaging modality 187 (77.9) 190 (82.3) 183 (82.4) 187 (86.2) 175 (91.1) 153 (78.1) 0.003 0.119
Use of TEE as initial imaging modality 36 (15.0) 26 (11.3) 28 (12.6) 26 (12.0) 10 (5.2) 33 (16.8) 0.012 0.566
Discharge medications
ACE inhibitors 84 (41.4) 126 (56.3) 112 (56.6) 100 (55.2) 97 (53.6) 98 (54.4) 0.019 0.061
Angiotensin II receptor blockers — 1 (7.1) 6 (9.7) 10 (10.9) 27 (16.4) 40 (23.4) 0.034 0.002
Beta-blockers 183 (83.9) 214 (91.8) 196 (96.1) 171 (91.9) 186 (94.4) 177 (91.2) <0.001 0.011
Calcium-channel blockers 114 (55.3) 144 (64.6) 130 (64.7) 121 (66.5) 124 (65.6) 116 (63.7) 0.207 0.098
Diuretic — 9 (64.3) 25 (38.5) 33 (34.0) 61 (37.7) 79 (45.7) 0.114 0.546
Statins — 1 (7.1) 8 (14.3) 20 (28.6) 62 (43.1) 72 (45.6) <0.001 <0.001
Vasodilators 58 (29.1) 83 (39.2) 60 (31.9) 28 (18.8) 40 (28.0) 33 (24.3) 0.001 0.014
In-hospital management and outcomes
Surgical management 43 (17.3) 45 (16.8) 28 (12.1) 43 (16.5) 14 (6.4) 19 (7.6) <0.001 <0.001
Medical management 187 (75.4) 173 (64.6) 155 (67.1) 140 (53.6) 127 (57.7) 141 (56.6) <0.001 <0.001
Endovascular management 18 (7.3) 49 (18.3) 48 (20.8) 74 (28.4) 75 (34.1) 77 (30.9) <0.001 <0.001
Hybrid management 0 (0.0) 1 (0.4) 0 (0.0) 4 (1.5) 4 (1.8) 12 (4.8) <0.001 <0.001
Overall mortality 30 (12.1) 34 (12.7) 19 (8.2) 20 (7.7) 20 (9.1) 35 (14.1) 0.103 0.915
Surgical mortality 13 (30.2) 12 (26.7) 1 (3.6) 3 (7.0) 0 (0.0) 4 (21.1) 0.003 0.007
Medical mortality 17 (9.1) 16 (9.2) 11 (7.1) 10 (7.1) 9 (7.1) 17 (12.1) 0.630 0.705
Endovascular mortality 0 (0.0) 6 (12.2) 7 (14.6) 7 (9.5) 10 (13.3) 12 (15.6) 0.528 0.216
Values are mean  SD or n (%).
Abbreviations as in Table 3.
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356cross-sectional imaging, 85% of patients were found
to have chest x-rays with an abnormal aortic contour,
widened superior mediastinum, or separation of the
aortic wall intimal calciﬁcation from the outer margin
of the aorta (25). The reported incidence of normal
chest x-rays among patients with AAD has increased
over time. Furthermore, the ﬁnding of a widened
mediastinum on chest x-rays of IRAD patients has
been less frequent than historic norms and has been
found in only 54.3% of type A patients and 43.1% of
type B patients. The reason for this change is not
entirely clear. One possibility is that with the
increased use of and emphasis on the diagnosticcapabilities of chest CT, less attention has been paid
to the conventional chest x-ray. It is also possible that
chest x-rays are currently obtained in only a subset of
patients because many patients with suspected AAD
are referred directly to chest CT. In addition, many
patients with AAD do not have dilation of the aorta,
which would be evident on a chest x-ray (27).
The use of chest CT has increased signiﬁcantly in
AAD and has become the imaging modality of ﬁrst
choice for the diagnosis of AAD. Improved spatial
resolution, faster scanning rates, algorithms to limit
radiation dose, increased availability, and reduced
cost likely account for its greater rate of use. The
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357frequency of the use of TEE as the initial diagnostic
imaging study has also decreased.
Signiﬁcant trends in type A medications prescribed
at discharge were noted, with more beta-blockers
and statins being prescribed in recent years, but
fewer diuretics and other vasodilators. Type B pa-
tients received more discharge angiotensin receptor
blockers, beta-blockers, and statins but received
fewer vasodilators. As awareness of the importance of
blood pressure management increases, especially in
the post-dissection patient, it is possible that physi-
cians have more diligently attempted to achieve the
blood pressure targets recommended by national
guidelines (28). Furthermore, studies on the impact
of angiotensin on aortic dilation have correlated
temporally with a signiﬁcant increase in the use of
these drugs in type B AAD patients with descending
thoracic aortic disease (29,30). It was not possible to
ascertain the reasons for some of these trends from
the data available through IRAD.
Advances in the treatment of AAD were reﬂected
in our IRAD ﬁndings. The number of type A patients
who underwent surgical intervention increased sig-
niﬁcantly over time, likely due in part to more rapid
diagnosis, the increased safety and efﬁcacy of aortic
replacement procedures, and advances in hypother-
mic circulatory arrest, cerebral perfusion strategies,
cardiopulmonary bypass, and post-operative care. In
type B patients, the use of endovascular therapies as
alternatives to medical and open surgical strategies
increased signiﬁcantly over time (20). The potential
impact of aortic remodeling on longer term aortic and
clinical outcomes in patients who received a stent
graft requires further study. A single randomized
study demonstrated improved survival for uncom-
plicated type B patients at 5 years post-dissection
compared with those who received medical therapy
alone (10,19). Furthermore, the less invasive endo-
vascular strategy was shown in observational studies
to favorably inﬂuence mortality in complicated type B
AAD patients, who would have required open surgical
management in the past (31).
In the 17-year span over which this analysis was
performed, overall mortality in patients with type A
AAD declined. Notably, surgical mortality in patients
with type A and type B AAD decreased signiﬁcantly.
Bekkers et al. (32) recently reported the evolution
of surgical techniques and reduced mortality in
an observational series of 232 type A AAD patients
operated on between 1972 and 2011. Improvements
in AAD outcomes were likely due to a number of
factors: earlier detection, improved diagnostic imag-
ing, advances in surgical and endovascular tech-
niques, and coordinated post-operative and medicalmanagement. One of the goals of reporting the ob-
servations from IRAD is to increase awareness of AAD,
its various presentations, diagnostic and treatment
strategies, and outcomes, thereby improving the care
of these patients worldwide.
Detailed data on the use of differing surgical tech-
niques, such as methods of cerebral perfusion and
hybrid procedures, were not included in the initial
IRAD data collection, although more detailed surgical
data are being collected prospectively in a subset of
patients. Endovascular stent grafting for complicated
type B AAD has only recently become a component of
routine care, based largely on observational outcomes.
STUDY LIMITATIONS. IRAD participation is volun-
tary; thus, our observations were limited by the
constraints imposed by data collection from a limited
number of sites involved in the care of patients with
AAD. There is no core laboratory to review images,
and all investigators are responsible for reporting
patient ﬁndings at their institutions. Most of the data
regarding patient history and physical examination
ﬁndings are obtained by retrospective chart review.
The participating centers are tertiary referral cen-
ters, and thus the patients are by deﬁnition those who
survive to arrive at such centers. Although partici-
pating investigators attempt to include all patients at
their institutions, there is no certainty that the reg-
istry is representative of all patients with AAD. Little
information is available regarding cause of death in
the IRAD population; therefore, we could not eval-
uate changes in the cause of death over time.
CONCLUSIONS
The most notable changes over time in the presenta-
tion, diagnosis, treatment, and outcomes of patients
with AAD include an increase in the frequency of use
of chest CT as the primary imaging modality, an in-
crease in the frequency with which normal chest
x-rays are reported, more frequent treatment of type
A patients with surgery, and increased use of endo-
vascular therapies for the management of patients
with complicated type B AAD. Type A patients
demonstrated improved mortality over time, both
overall and among surgical patients alone. Observa-
tional registry data of the type reported from IRAD are
an important source of information that can be used
to inﬂuence algorithms for diagnosis and treatment.
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PERSPECTIVES
COMPETENCY IN SYSTEMS-BASED PRACTICE:
Patients with type A AAD have been more frequently
managed surgically in recent years with decreasing
mortality, and endovascular repair is increasingly used at
referral centers for patients with complicated type B
dissection.
TRANSLATIONAL OUTLOOK: Evaluation of the rela-
tive efﬁcacy of available alternative management strate-
gies for patients with AAD dissection would optimally be
derived from randomized trials. Because of the acuity,
unpredictability, and diversity of clinical presentations,
resources, and practice patterns, innovative regionally
oriented trial designs are needed.
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